Standard
Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance. / Gault, Victor ; Lennox, R.; Porter, David et al.
In:
Diabetic Medicine, Vol. 30, No. Supplement 1, A9 (P99), 03.2013, p. 4.
Research output: Contribution to Journal/Magazine › Meeting abstract › peer-review
Harvard
Gault, V, Lennox, R, Porter, D
, Holscher, C & Flatt, P 2013, '
Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance',
Diabetic Medicine, vol. 30, no. Supplement 1, A9 (P99), pp. 4.
https://doi.org/10.1111/dme.12090_3
APA
Gault, V., Lennox, R., Porter, D.
, Holscher, C., & Flatt, P. (2013).
Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance.
Diabetic Medicine,
30(Supplement 1), 4. Article A9 (P99).
https://doi.org/10.1111/dme.12090_3
Vancouver
Author
Bibtex
@article{bd4668bae7ac41bd90e05ee97d7dfc56,
title = "Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance",
author = "Victor Gault and R. Lennox and David Porter and Christian Holscher and Peter Flatt",
year = "2013",
month = mar,
doi = "10.1111/dme.12090_3",
language = "English",
volume = "30",
pages = "4",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "Supplement 1",
}
RIS
TY - JOUR
T1 - Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance
AU - Gault, Victor
AU - Lennox, R.
AU - Porter, David
AU - Holscher, Christian
AU - Flatt, Peter
PY - 2013/3
Y1 - 2013/3
U2 - 10.1111/dme.12090_3
DO - 10.1111/dme.12090_3
M3 - Meeting abstract
VL - 30
SP - 4
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - Supplement 1
M1 - A9 (P99)
ER -